HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberto Ronca Selected Research

Fibroblast Growth Factors (Fibroblast Growth Factor)

3/2022Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives.
1/2021Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88.
1/2021The FGF/FGFR system in the physiopathology of the prostate gland.
12/2020Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress.
1/2020FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress.
9/2019The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach.
1/2018Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth.
1/2018Future applications of FGF/FGFR inhibitors in cancer.
11/2017Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.
10/2017Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberto Ronca Research Topics

Disease

52Neoplasms (Cancer)
12/2022 - 04/2002
6Prostatic Neoplasms (Prostate Cancer)
01/2022 - 06/2013
5Breast Neoplasms (Breast Cancer)
12/2022 - 09/2011
4Inflammation (Inflammations)
09/2019 - 06/2009
3Multiple Myeloma
05/2021 - 05/2019
3Neoplasm Metastasis (Metastasis)
01/2021 - 03/2015
3Adenocarcinoma
10/2017 - 06/2003
2Hypoxia (Hypoxemia)
12/2022 - 01/2016
2Glioblastoma (Glioblastoma Multiforme)
12/2022 - 12/2022
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2021
2Urinary Bladder Neoplasms (Bladder Cancer)
12/2021 - 08/2019
2Uveal melanoma
12/2021 - 09/2019
2Melanoma (Melanoma, Malignant)
11/2020 - 12/2013
2Fibrosarcoma
09/2019 - 01/2018
2Globoid Cell Leukodystrophy (Krabbe Disease)
04/2014 - 09/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2022
1Acidosis
12/2022
1Pathologic Processes
03/2022
1Fibrosis (Cirrhosis)
01/2021
1Wounds and Injuries (Trauma)
01/2021
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2020
1Lung Neoplasms (Lung Cancer)
12/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2020
1Skin Neoplasms (Skin Cancer)
11/2020
1Nevus (Nevi)
11/2020

Drug/Important Bio-Agent (IBA)

16Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
03/2022 - 12/2010
13Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
09/2019 - 06/2003
11Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
03/2022 - 04/2005
7Proteins (Proteins, Gene)FDA Link
12/2022 - 08/2005
7PTX3 proteinIBA
05/2021 - 06/2013
6Biological ProductsIBA
12/2021 - 08/2005
5fosbretabulin (combretastatin A4)IBA
03/2021 - 01/2017
5LigandsIBA
12/2020 - 01/2015
5CytokinesIBA
01/2020 - 04/2005
5TubulinIBA
11/2019 - 04/2015
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 06/2003
4Pharmaceutical PreparationsIBA
12/2021 - 01/2017
4AntibodiesIBA
01/2021 - 01/2009
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 06/2003
3EnzymesIBA
12/2022 - 09/2013
3AndrogensIBA
01/2022 - 09/2011
3Tyrosine Kinase InhibitorsIBA
12/2020 - 01/2015
3GalactosylceramidaseIBA
11/2020 - 09/2013
3Antimitotic AgentsIBA
01/2017 - 01/2016
2Carbonic Anhydrases (Carbonic Anhydrase)IBA
12/2022 - 12/2021
2Carbonic Anhydrase IXIBA
12/2022 - 12/2021
2SLC-0111IBA
12/2022 - 12/2022
2Carbonic Anhydrase InhibitorsIBA
12/2022 - 12/2022
2enzalutamideIBA
01/2022 - 01/2020
2Protein Isoforms (Isoforms)IBA
12/2021 - 11/2021
2Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2021
2LuciferasesIBA
12/2021 - 03/2015
2Phosphates (Orthophosphate)IBA
08/2020 - 09/2019
2Caveolin 1IBA
01/2019 - 06/2015
2Antineoplastic Agents (Antineoplastics)IBA
10/2018 - 09/2011
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018 - 01/2012
2Angiogenesis InhibitorsIBA
01/2018 - 11/2017
2Pattern Recognition ReceptorsIBA
01/2018 - 05/2015
2SteroidsIBA
05/2015 - 09/2011
2Hormones (Hormone)IBA
05/2015 - 09/2011
2Psychosine (Galactosylsphingosine)IBA
04/2014 - 09/2013
2Dihydrotestosterone (Androstanolone)IBA
06/2013 - 09/2011
2Complementary DNA (cDNA)IBA
12/2009 - 06/2003
2Tetracycline (Achromycin)FDA LinkGeneric
12/2009 - 06/2003
2ChemokinesIBA
06/2009 - 04/2005
1Acetazolamide (Diamox)FDA LinkGeneric
12/2022
1BenzenesulfonamidesIBA
12/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1pemigatinibIBA
01/2022
1Metalloproteases (Metalloproteinases)IBA
01/2022
1MonosaccharidesIBA
12/2021
1EverolimusFDA Link
12/2021
1PanobinostatIBA
12/2021
1Paclitaxel (Taxol)FDA LinkGeneric
12/2021
1Antisense OligonucleotidesIBA
11/2021
1PalladiumIBA
03/2021
1PyrrolesIBA
03/2021
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2021
1ApoferritinsIBA
01/2021
1Ferritins (Ferritin)IBA
01/2021
1CollagenIBA
01/2021
1erdafitinibIBA
12/2020
1Microphthalmia-Associated Transcription FactorIBA
11/2020
1CeramidesIBA
11/2020
1SphingolipidsIBA
11/2020
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
11/2020
1Monophenol Monooxygenase (Tyrosinase)IBA
11/2020
1Bortezomib (Velcade)FDA Link
01/2020
1AntioxidantsIBA
01/2020
1CatalaseIBA
01/2020

Therapy/Procedure

22Therapeutics
12/2022 - 04/2002
2Radiotherapy
12/2022 - 03/2022
2Drug Therapy (Chemotherapy)
03/2022 - 01/2020
2Castration
01/2022 - 01/2020
1Induced Hyperthermia (Thermotherapy)
03/2022
1Cryotherapy (Therapy, Cold)
03/2022
1Quantum Dots (Quantum Dot)
12/2021